Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TelyRx HoldingsTSX:TELY +13.04%12 Gross Margin % is 55.21% as of Mar. 2026, which is 50% above its 10-year median of 36.84. GuruFocus rates TSX:TELY with a GF Score™ of 12/100. The stock has 1 warning sign investors should review. Among 628 Healthcare Providers & Services companies, TelyRx Holdings ranks better than 65.29% on this metric.
The historical rank and industry rank for TelyRx Holdings's Gross Margin % or its related term are showing as below:
TSX:TELY'
s Gross Margin % Range Over the Past 10 Years
Min: 8.33 Med: 36.84 Max: 55.26
Current: 55.26
During the past 3 years, the highestGross Margin % of TelyRx Holdings was 55.26%. The lowest was 8.33%. And the median was 36.84%.
TSX:TELY's Gross Margin % is ranked better than 65.29% of 628
companies
in the Healthcare Providers & Services industry
Industry Median: 40.075
vs TSX:TELY: 55.26
TelyRx Holdings had a gross margin of 55.21% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for TelyRx Holdings was 0.00% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
TelyRx Holdings had a gross margin of 55.21% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
TelyRx Holdings Gross Margin % Related Terms
TelyRx Holdings Gross Margin % Historical Data
* Premium members only.
The historical data trend for TelyRx Holdings's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, TelyRx Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TelyRx Holdings Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, TelyRx Holdings's Gross Margin % distribution charts can be found below:
* The bar in red indicates where TelyRx Holdings's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
TelyRx Holdings (TSX:TELY) has a Gross Margin % of 55.21% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on TelyRx Holdings and its competitors. This is 50% above median its historical median of 36.84. Over the past decade, TelyRx Holdings' Gross Margin % has ranged from 8.33 to 55.26. According to the industry distribution chart, TelyRx Holdings ranks #218 out of 628 companies in the Healthcare Providers & Services industry, placing it in the top 34.7%.
Is TelyRx Holdings' Gross Margin % too high?
TelyRx Holdings' current Gross Margin % of 55.21% is 50% above median its 10-year median of 36.84. Over the past 10 years, this metric has ranged from a low of 8.33 to a high of 55.26. The Healthcare Providers & Services industry median Gross Margin % is 40.08. TelyRx Holdings' value of 55.21% is 37.8% above this industry median. Based on the distribution chart, TelyRx Holdings ranks #218 out of 628 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, TelyRx Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does TelyRx Holdings' Gross Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, TelyRx Holdings ranks #218 out of 628 companies for Gross Margin %. This puts TelyRx Holdings in the upper half of its industry. The industry median Gross Margin % is 40.08. TelyRx Holdings' value of 55.21% is 37.8% above this benchmark. Historically, TelyRx Holdings' own Gross Margin % has ranged from 8.33 to 55.26 over the past decade. While the company's 10-year median is 36.84 vs. the industry median of 40.08, TelyRx Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.08, based on 628 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TelyRx Holdings's current Gross Margin % of 55.21% is 37.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on TelyRx Holdings and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TelyRx Holdings's current Gross Margin % is 55.21%, which is 50% above median its own 10-year median of 36.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TelyRx Holdings stock overvalued right now?
TelyRx Holdings (TSX:TELY) has a current Gross Margin % of 55.21%. The current Gross Margin % is 55.21%, which is 50% above median its 10-year median of 36.84 and 37.8% above the Healthcare Providers & Services industry median of 40.08. TelyRx Holdings' overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For TelyRx Holdings (TSX:TELY), the current Gross Margin % is 55.21% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
TelyRx Holdings Inc is a vertically integrated technology enabled healthcare and pharmacy services provider, operating a digital pharmacy platform that connects patients with independent, state-licensed providers. The TelyRx platform provides the Providers with access to a clinically focused electronic medical records system and the ability for them to electronically prescribe. TelyRx enables patient access to a risk-curated formulary of over 450 noncontrolled, and non-compounded prescription medications selected by the Providers to address a broad cross-section of everyday chronic and acute ailments.
12GF Score
Get the complete analysis for TSX:TELY
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSX:TELY has been successfully added to your 
